Prothena | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Biogen USD 311.2M 130.2M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Exelixis USD 163.21M 27.13M 2025-01
Incyte USD 205.17M 96.34M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
MacroGenics USD -16587000 70.78M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Prothena USD -64897000 1.62M 2024-12
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



Prothena Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.